Indeed, cognitive decline has been reported in patients with mitochondrial disease previously [28, 29], and a loss of calbindin‐positive interneurones is implicated in the development of cognitive impairments in patients harbouring the m.3243A>G mutation [30]. This evidence concerns the gene CALB1 and inborn mitochondrial metabolism disorder.